Werewolf Therapeutics (HOWL) Financials: Revenue & Earnings

HOWL price $1.05 +0.01 +0.96%

Ticker
HOWL
Price
$1.05
Change
+0.01 +0.96%
Market cap ?
$51.03M
P/E ?
-1.37
Dividend yield ?
0.00%
Beta ?
0.29
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
58
Quality
38
Growth
100

Stocklytics score rationale: value 58, quality 38, growth 100.

Financials

2019202020212022202320242025
000164010001994300018850000

Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory…

Fair value

HOWL fair value Not meaningful. Price $1.05.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare HOWL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.22—18.31M
2026-07-310.08-0.2821.00M21.00M
2026-05-07-0.28-0.32——
2026-03-27-0.20-0.34—300.00K
2025-11-04-0.36-0.39——
2025-08-14-0.40-0.50——
2025-05-08-0.40-0.44—375.00K
2025-03-11-0.46-0.43—301.59K
2024-11-07-0.38-0.41—709.32K
2024-08-08-0.40-0.381.14M841.78K
2024-05-03-0.39-0.35742.00K1.46M
2024-03-07-0.33-0.431.50M1.94M
2023-11-14-0.23-0.395.90M1.59M
2023-08-10-0.14-0.428.08M3.15M
2023-05-11-0.34-0.504.46M2.03M
2023-03-23-0.39-0.557.28M2.07M
2022-11-10-0.40-0.604.97M3.05M
2022-08-11-0.53-0.434.15M5.00M
2022-05-10-0.56-0.61——
2022-03-24-0.66-0.53——
2021-11-10-0.51-0.44——
2021-08-12-3.82-0.37——
2021-06-10-83.36-0.46——
2021-04-30-0.83———
2020-09-30-0.68———
2020-06-300.25———
2020-03-31-0.43———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-07EVNIN LUKESell107.43K$0.3133.30K
2026-07-06EVNIN LUKESell35.77K$0.3211.45K
2026-06-29EVNIN LUKESell157.08K$0.3047.13K
2026-06-17RA CAPITAL MANAGEMENT, L.P.Sell389.22K$0.35136.23K
2026-06-17RA CAPITAL MANAGEMENT, L.P.Sell27.70K$0.359.69K
2026-06-16RA CAPITAL MANAGEMENT, L.P.Sell139.69K$0.3751.68K
2026-06-16RA CAPITAL MANAGEMENT, L.P.Sell9.94K$0.373.68K
2026-06-15RA CAPITAL MANAGEMENT, L.P.Sell120.22K$0.3946.88K
2026-06-15RA CAPITAL MANAGEMENT, L.P.Sell8.55K$0.393.34K
2026-06-12RA CAPITAL MANAGEMENT, L.P.Sell159.12K$0.4063.65K
2026-06-12RA CAPITAL MANAGEMENT, L.P.Sell11.32K$0.404.53K
2026-06-11RA CAPITAL MANAGEMENT, L.P.Sell245.07K$0.3893.13K
2026-06-11RA CAPITAL MANAGEMENT, L.P.Sell17.44K$0.386.63K
2026-06-10RA CAPITAL MANAGEMENT, L.P.Sell42.87K$0.3715.86K
2026-06-10RA CAPITAL MANAGEMENT, L.P.Sell3.05K$0.371.13K
2026-06-09RA CAPITAL MANAGEMENT, L.P.Sell345.24K$0.37127.74K
2026-06-09RA CAPITAL MANAGEMENT, L.P.Sell24.57K$0.379.09K
2026-06-09EVNIN LUKESell76.93K$0.3728.46K
2026-06-08EVNIN LUKESell60.55K$0.4024.22K
2026-06-05EVNIN LUKESell24.95K$0.409.98K
2026-06-04EVNIN LUKESell20.07K$0.448.83K
2026-06-03EVNIN LUKESell29.75K$0.4212.49K
2026-06-02EVNIN LUKESell29.59K$0.4513.32K
2026-06-01EVNIN LUKESell80.46K$0.4737.82K
2026-05-29EVNIN LUKESell32.56K$0.4514.65K
2026-05-28EVNIN LUKESell27.70K$0.4612.74K
2026-05-27EVNIN LUKESell80.85K$0.4838.81K
2026-05-26EVNIN LUKESell67.95K$0.4731.94K
2026-05-22EVNIN LUKESell87.42K$0.4539.34K
2026-05-21EVNIN LUKESell36.39K$0.4215.28K
2026-05-20EVNIN LUKESell85.89K$0.4336.93K
2026-05-19EVNIN LUKESell62.97K$0.4528.34K
2026-05-18EVNIN LUKESell22.18K$0.5011.09K
2026-05-13EVNIN LUKESell44.68K$0.5424.13K
2026-05-12EVNIN LUKESell67.89K$0.6443.45K
2026-05-12RA CAPITAL MANAGEMENT, L.P.Sell94.43K$0.6460.44K
2026-05-12RA CAPITAL MANAGEMENT, L.P.Sell6.72K$0.644.30K
2026-05-11EVNIN LUKESell33.95K$0.6722.75K
2026-05-11RA CAPITAL MANAGEMENT, L.P.Sell81.68K$0.6754.72K
2026-05-11RA CAPITAL MANAGEMENT, L.P.Sell5.81K$0.673.89K
2026-05-08EVNIN LUKESell305.74K$0.70214.02K
2026-05-08RA CAPITAL MANAGEMENT, L.P.Sell351.51K$0.71249.57K
2026-05-08RA CAPITAL MANAGEMENT, L.P.Sell25.01K$0.7117.76K
2026-05-07EVNIN LUKESell79.09K$0.6349.82K
2026-05-06EVNIN LUKESell14.63K$0.669.66K
2026-05-05EVNIN LUKESell6.86K$0.694.73K
2026-05-04EVNIN LUKESell47.96K$0.7234.53K
2026-05-01EVNIN LUKESell58.39K$0.7342.63K
2026-04-30EVNIN LUKESell168.26K$0.72121.15K
2026-04-29EVNIN LUKESell56.56K$0.6939.03K
2026-04-28EVNIN LUKESell95.41K$0.7369.65K
2026-04-27EVNIN LUKESell53.94K$0.8545.85K
2026-02-13Urban Michael J.Other0——
2026-02-13Urban Michael J.Other52.50K$3.65191.62K
2026-02-13Urban Michael J.Other29.36K$4.64136.25K
2026-02-13Urban Michael J.Other10.00K$1.5715.70K
2026-02-13Urban Michael J.Other54.80K$1.5685.49K
2026-01-16EVNIN LUKESell38.78K$0.5420.94K
2026-01-15EVNIN LUKESell37.41K$0.5520.58K
2026-01-14EVNIN LUKESell30.62K$0.5717.45K
2026-01-13EVNIN LUKESell43.20K$0.5523.76K
2026-01-12EVNIN LUKESell58.98K$0.5733.62K
2026-01-09EVNIN LUKESell24.68K$0.6115.05K
2026-01-08EVNIN LUKESell7.72K$0.634.86K
2026-01-07EVNIN LUKESell11.91K$0.647.63K
2026-01-06EVNIN LUKESell40.76K$0.6526.49K
2026-01-05EVNIN LUKESell18.38K$0.6411.76K
2026-01-02EVNIN LUKESell18.57K$0.6311.70K
2025-12-31EVNIN LUKESell24.96K$0.6215.48K
2025-12-30EVNIN LUKESell34.85K$0.6121.26K
2025-12-29EVNIN LUKESell108.61K$0.6166.25K
2025-12-26EVNIN LUKESell35.63K$0.6322.45K
2025-12-24EVNIN LUKESell16.31K$0.6510.60K
2025-12-23EVNIN LUKESell71.43K$0.6345.00K
2025-12-22EVNIN LUKESell59.31K$0.6940.92K
2025-12-17EVNIN LUKESell9.98K$1.1411.38K
2025-12-16EVNIN LUKESell14.55K$1.0515.28K
2025-12-15EVNIN LUKESell23.64K$1.0725.29K
2025-12-12EVNIN LUKESell17.86K$1.0819.29K
2025-12-11EVNIN LUKESell28.01K$1.0729.97K
2025-12-10EVNIN LUKESell37.10K$1.0639.33K
2025-12-09EVNIN LUKESell44.57K$1.0145.02K
2025-12-08EVNIN LUKESell34.04K$0.9933.70K
2025-12-05EVNIN LUKESell16.57K$0.9716.07K
2025-12-04EVNIN LUKESell53.42K$0.9751.81K
2025-12-04MPM BioVentures 2014, L.P.Sell83.23K$0.9780.73K
2025-12-04GADICKE ANSBERTSell83.23K$0.9780.73K
2025-12-03EVNIN LUKESell36.73K$0.8731.95K
2025-12-03MPM BioVentures 2014, L.P.Sell57.23K$0.8749.79K
2025-12-03GADICKE ANSBERTSell57.23K$0.8749.79K
2025-12-02EVNIN LUKESell38.04K$0.8933.86K
2025-12-02MPM BioVentures 2014, L.P.Sell59.28K$0.8952.76K
2025-12-02GADICKE ANSBERTSell59.28K$0.8952.76K
2025-12-01EVNIN LUKESell39.10K$0.9436.75K
2025-12-01MPM BioVentures 2014, L.P.Sell60.92K$0.9457.26K
2025-12-01GADICKE ANSBERTSell60.92K$0.9457.26K
2025-11-28EVNIN LUKESell13.01K$0.9912.88K
2025-11-28MPM BioVentures 2014, L.P.Sell20.28K$0.9920.07K
2025-11-28GADICKE ANSBERTSell20.28K$0.9920.07K
2025-11-26EVNIN LUKESell38.98K$0.9838.20K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 47, holders -1 vs prior quarter. Ownership 22.36%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.2.39M-4.29M-64.26%859.35K
BALYASNY ASSET MANAGEMENT L.P.1.79M1.79MNew644.25K
VANGUARD CAPITAL MANAGEMENT LLC1.22M00.00%438.47K
RENAISSANCE TECHNOLOGIES LLC674.63K158.41K+30.69%242.80K
LYNX1 CAPITAL MANAGEMENT LP657.79K00.00%236.74K
SPHERA FUNDS MANAGEMENT LTD.626.81K00.00%225.59K
DC FUNDS, LP589.10K00.00%212.02K
VERDAD ADVISERS, LP348.71K318.95K+1071.74%125.50K
GEODE CAPITAL MANAGEMENT, LLC335.81K-53.67K-13.78%120.89K
BANK OF AMERICA CORP /DE/311.50K46.92K+17.73%111.83K
XTX TOPCO LTD271.48K220.55K+433.05%97.70K
JANE STREET GROUP, LLC251.84K169.00K+204.02%90.64K
UBS GROUP AG215.84K148.98K+222.84%77.70K
VANGUARD FIDUCIARY TRUST CO157.73K00.00%56.78K
STATE STREET CORP119.17K00.00%42.89K
SQUAREPOINT OPS LLC103.24K103.24KNew37.16K
BLACKROCK, INC.101.57K-35-0.03%36.56K
RANGELEY CAPITAL, LLC100.00K100.00KNew35.99K
NORTHERN TRUST CORP86.85K00.00%31.26K
ALYESKA INVESTMENT GROUP, L.P.86.55K00.00%31.15K
MPM BIOIMPACT LLC80.14K-1.13M-93.37%28.85K
CITADEL ADVISORS LLC75.00K64.62K+622.40%26.99K
MILLENNIUM MANAGEMENT LLC62.05K-70.00K-53.01%22.33K
VIRTU FINANCIAL LLC45.47K45.47KNew16.00K
GSA CAPITAL PARTNERS LLP27.15K27.15KNew10.00K

Earnings and financials

Werewolf Therapeutics, Inc. (HOWL) trades at $1.05, with a market cap of $51.03M and a trailing P/E of -1.37. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
000164010001994300018850000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Werewolf Therapeutics (HOWL) Financials: Revenue & Earnings

HOWL$1.05+0.01 +0.96%

$51.03M

Market Cap

-1.37

P/E

—

Forward P/E

65

Score

Price History